CN106389569A - Traditional Chinese medicine composition for treating upper respiratory inflammation - Google Patents

Traditional Chinese medicine composition for treating upper respiratory inflammation Download PDF

Info

Publication number
CN106389569A
CN106389569A CN201610995438.7A CN201610995438A CN106389569A CN 106389569 A CN106389569 A CN 106389569A CN 201610995438 A CN201610995438 A CN 201610995438A CN 106389569 A CN106389569 A CN 106389569A
Authority
CN
China
Prior art keywords
parts
chinese medicine
medicine composition
traditional chinese
radix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201610995438.7A
Other languages
Chinese (zh)
Inventor
李云娟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chengdu Yue Lun Trading Co Ltd
Original Assignee
Chengdu Yue Lun Trading Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chengdu Yue Lun Trading Co Ltd filed Critical Chengdu Yue Lun Trading Co Ltd
Priority to CN201610995438.7A priority Critical patent/CN106389569A/en
Publication of CN106389569A publication Critical patent/CN106389569A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/34—Campanulaceae (Bellflower family)
    • A61K36/346—Platycodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/714—Aconitum (monkshood)

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Botany (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine composition for treating upper respiratory inflammation. The traditional Chinese medicine composition comprises, by weight, 3-9 parts of kelp, 5-8 parts of radix aconiti carmichaeli, 4-11 parts of platycodon grandiflorum, 6-10 parts of folium eriobotryae, 5-14 parts of fewflower lysionotus herb, 3-7 parts of inula japonica, 5-13 parts of thorny elaeagnus leaf, 2-9 parts of affine cudweed, 6-12 parts of radix asteris and 4-8 parts of seaweed. The traditional Chinese medicine composition has the advantages that the problem of the upper respiratory inflammation is solved fundamentally by researching the symptoms and causes of respiratory diseases for a long time and by using the traditional Chinese medicine composition; compared with western medicine, the traditional Chinese medicine composition can relieve symptoms such as cough, sore throat and swallow paint caused by the inflammation and can also treat root causes, and repeated attacks of the respiratory diseases can be prevented; compared with existing traditional Chinese medicine, the traditional Chinese medicine composition is clear in component, evident in preparation effect and applicable to the respiratory diseases caused by various causes.

Description

A kind of Chinese medicine composition treating upper respiratory tract infection
Technical field
The present invention relates to tcm field, specifically refer to a kind of Chinese medicine composition treating upper respiratory tract infection.
Background technology
Upper respiratory tract infection has 70%～80% to be caused by virus.Including rhinovirus, coronavirus, adenoviruss, influenza and pair Influenza virus, respiratory syncytial virus, echovirus, Coxsackie viruss etc..The upper sense separately having 20%～30% is caused by antibacterial.Carefully Bacterium infection can direct infection or after being secondary to virus infection, secondly be most common with Hemolytic streptococcuss, be the bloodthirsty bar of influenza Bacterium, streptococcus pneumoniae, staphylococcuses etc., occasionally for gram-negative bacteria.Various lead to whole body or respiratory tract local defense function fall Low the reason, such as suffer from cold, drench with rain, abrupt change of climate, fatigue etc. can make former being present in upper respiratory tract or invade from extraneous Virus or antibacterial breed rapidly, thus inducing primary disease.Old germling is weak, immunologic hypofunction or with chronic respiratory tract disease Patient susceptible.Treatment upper respiratory tract infection should distinguish inflammatory type, using Western medicine, Chinese medicine all can, and Chinese medicine be used for treatment Respiratory tract infection medicine, due to having Small side effects, eutherapeutic feature, therefore is favored by people very much.
Content of the invention
It is an object of the invention to provide a kind of can fundamentally effectively solving upper respiratory tract infection from inside to outside Chinese medicine Compositionss.
The present invention is achieved through the following technical solutions：A kind of Chinese medicine composition treating upper respiratory tract infection, described Chinese medicine Composition components include Thallus Laminariae (Thallus Eckloniae) 3-9 part, Radix Aconiti Lateralis Preparata 5-8 part, Radix Platycodoniss 4-11 part, Folium Eriobotryae 6-10 part, Herba Lysionoti Pauciflori 5-14 part, Flos Inulae 3-7 part, Folium Elaeagni 5-13 part, Herba Gnaphalii Affinis 2-9 part, Radix Asteriss 6-12 part, Sargassum 4-8 part.
A kind of crude drug pharmacology of Chinese medicine composition for treating hypertrophic gastritis of the present invention：
Thallus Laminariae (Thallus Eckloniae)：Cold in nature, salty in the mouth.Return liver warp, stomach, kidney channel.Hard masses softening and resolving, expectorant, diuretic.Belong to expectorants, antitussives and anti-asthmatics medicine subordinate to divide The medicine for the treatment of cough and asthma of class.
Radix Aconiti Lateralis Preparata：Warm in nature, acrid in the mouth.Poisonous.Return stomach, Liver Channel.Wind-dispelling expectorant, arresting convulsion jerk, detoxify, eliminating stagnation, pain relieving.Belong to resolving sputum to stop Cough the medicine for warming and resolving cold-phlegm of anti-asthmatic subordinate classification.
Radix Platycodoniss：Mild-natured, bitter in the mouth, pungent.Return lung warp.Lung qi dispersing eliminating the phlegm, sore-throat relieving evacuation of pus.Under genus expectorants, antitussives and anti-asthmatics medicine, classification is clear Change heat-phlegm medicine.
Folium Eriobotryae：Bitter in the mouth, cold nature.Return lung warp, stomach.Clearing away lung-heat to relieve cough, stopping nausea and vomiting by lowering the adverse flow of QI.Belong to expectorants, antitussives and anti-asthmatics medicine subordinate In medicine for the treatment of cough and asthma.
Herba Lysionoti Pauciflori：Warm in nature, bitter in the mouth.Return lung warp.Preventing phlegm from forming and stopping coughing, hard masses softening and resolving.Belong to expectorants, antitussives and anti-asthmatics medicine subordinate classification Medicine for warming and resolving cold-phlegm.
Flos Inulae：Slightly warm in nature is bitter in the mouth, pungent, salty.Return lung warp, stomach.Sending down the abnormal ascending QI, expectorant, Hang Shui, preventing or arresting vomiting.Belong to preventing phlegm from forming and stopping coughing to put down Breathe heavily the medicine for warming and resolving cold-phlegm of classification under medicine.
Folium Elaeagni：Mild-natured, sour in the mouth.Return lung warp.Astringe the lung, relieving asthma, cough-relieving.Belong to stopping of expectorants, antitussives and anti-asthmatics medicine subordinate classification Cough anti-asthmatic.
Herba Gnaphalii Affinis：Mild-natured, sweet in the mouth.Return lung warp.Eliminating the phlegm, relieving cough and asthma, wind-damp dispelling.Belong to expectorants, antitussives and anti-asthmatics medicine subordinate classification Medicine for the treatment of cough and asthma.
Radix Asteriss：Warm in nature, acrid in the mouth, hardship.Return lung warp.Nourishing the lung to keep the adverse QI downward, stopping coughing and removing phlegm.Belong to expectorants, antitussives and anti-asthmatics medicine subordinate classification Medicine for the treatment of cough and asthma.
Sargassum：Cold in nature, bitter in the mouth, salty.Return liver warp, stomach, kidney channel.Hard masses softening and resolving, expectorant, diuretic.Belong to expectorant cough suppressant and anti-asthmatic The drug of clearing away heat to resolve phlegm of medicine subordinate classification.
For optimizing the effect of drugs of medicine, further determine that, 7 parts of described Thallus Laminariae (Thallus Eckloniae), 5 parts of Radix Aconiti Lateralis Preparata, 5 parts of Radix Platycodoniss, Folium Eriobotryae 7 Part, 11 parts of Herba Lysionoti Pauciflori, 4 parts of Flos Inulae, 7 parts of Folium Elaeagni, 8 parts of Herba Gnaphalii Affinis, 9 parts of Radix Asteriss, 6 parts of Sargassum.
For optimizing the effect of drugs of medicine, further determine that, 9 parts of described Thallus Laminariae (Thallus Eckloniae), 7 parts of Radix Aconiti Lateralis Preparata, 10 parts of Radix Platycodoniss, Folium Eriobotryae 6 Part, 5 parts of Herba Lysionoti Pauciflori, 3 parts of Flos Inulae, 6 parts of Folium Elaeagni, 3 parts of Herba Gnaphalii Affinis, 7 parts of Radix Asteriss, 5 parts of Sargassum.
For optimizing the effect of drugs of medicine, further determine that, 3 parts of described Thallus Laminariae (Thallus Eckloniae), 6 parts of Radix Aconiti Lateralis Preparata, 8 parts of Radix Platycodoniss, Folium Eriobotryae 9 Part, 8 parts of Herba Lysionoti Pauciflori, 5 parts of Flos Inulae, 11 parts of Folium Elaeagni, 5 parts of Herba Gnaphalii Affinis, 6 parts of Radix Asteriss, 7 parts of Sargassum.
For optimizing the effect of drugs of medicine, further determine that, described Radix Aconiti Lateralis Preparata is Rhizoma Typhonii.
The present invention compared with prior art, has advantages below and beneficial effect：
The present invention, by the symptom of the respiratory tract disease that studies for a long period of time and the cause of disease, then fundamentally goes to solve using Chinese medicine formula The problem of respiratory inflammation, compared to Western medicine, Chinese medicine formula can not only be alleviated the cough that inflammation brings, laryngopharynx swelling and pain, swallow The symptoms such as pain, and can solve the problem that old complaint, prevent disease recurrent exerbation；Compared with existing Chinese medicine formula, inventive formulation Constitute clearly, the effect of preparation is substantially it is adaptable to the upper respiratory disease that causes of Different types of etiopathogenises.
Specific embodiment
Embodiments of the invention are described below in detail.
Embodiment 1：
A kind of Chinese medicine composition treating upper respiratory tract infection of the present embodiment, described pharmaceutical compositions include Thallus Laminariae (Thallus Eckloniae) 3-9 Part, Radix Aconiti Lateralis Preparata 5-8 part, Radix Platycodoniss 4-11 part, Folium Eriobotryae 6-10 part, Herba Lysionoti Pauciflori 5-14 part, Flos Inulae 3-7 part, Folium Elaeagni 5-13 part, Herba Gnaphalii Affinis 2-9 part, Radix Asteriss 6-12 part, Sargassum 4-8 part.
The preparation method of medicine of the present invention, comprises the following steps：
（1）Represented with weight portion, weigh Thallus Laminariae (Thallus Eckloniae) 3-9 part, Radix Aconiti Lateralis Preparata 5-8 part, Radix Platycodoniss 4-11 part, Folium Eriobotryae 6-10 part first, stone hangs Blue 5-14 part, Flos Inulae 3-7 part, Folium Elaeagni 5-13 part, Herba Gnaphalii Affinis 2-9 part, Radix Asteriss 6-12 part, Sargassum 4-8 part；
（2）The Chinese herb weighing is soaked 20-25 minute, then starts to add water to cook；
（3）Carry out being filtrated to get filtrate after decoction, then carry out heating the glue concentrating formation relative density for 0.8-1.1 by filtrate Shape thing, 92% ethanol being subsequently adding 2-4 times amount is sufficiently stirred for, and the liquid after stirring is carried out the low temperature cold of 30 hours Hide；
（4）Solution after cold preservation is filtered precipitate, then ethanol is reclaimed by the way of distillation；
（5）Add food preservative in the liquid after distillation, finally encapsulation finished product sterilization is carried out using pasteurization disappear Poison, obtains final product oral administration solution.
Embodiment 2：
A kind of Chinese medicine composition treating upper respiratory tract infection of the present embodiment, is represented with weight portion, 7 parts of described Thallus Laminariae (Thallus Eckloniae), Radix Aconiti Lateralis Preparata 5 Part, 5 parts of Radix Platycodoniss, 7 parts of Folium Eriobotryae, 11 parts of Herba Lysionoti Pauciflori, 4 parts of Flos Inulae, 7 parts of Folium Elaeagni, 8 parts of Herba Gnaphalii Affinis, 9 parts of Radix Asteriss, Sargassum 6 Part.
Embodiment 3：
A kind of Chinese medicine composition treating upper respiratory tract infection of the present embodiment, is represented with weight portion, 9 parts of described Thallus Laminariae (Thallus Eckloniae), Radix Aconiti Lateralis Preparata 7 Part, 10 parts of Radix Platycodoniss, 6 parts of Folium Eriobotryae, 5 parts of Herba Lysionoti Pauciflori, 3 parts of Flos Inulae, 6 parts of Folium Elaeagni, 3 parts of Herba Gnaphalii Affinis, 7 parts of Radix Asteriss, Sargassum 5 Part.
Embodiment 4：
A kind of Chinese medicine composition treating upper respiratory tract infection of the present embodiment, is represented with weight portion, 3 parts of described Thallus Laminariae (Thallus Eckloniae), Radix Aconiti Lateralis Preparata 6 Part, 8 parts of Radix Platycodoniss, 9 parts of Folium Eriobotryae, 8 parts of Herba Lysionoti Pauciflori, 5 parts of Flos Inulae, 11 parts of Folium Elaeagni, 5 parts of Herba Gnaphalii Affinis, 6 parts of Radix Asteriss, Sargassum 7 Part.
It is directed to the clinical statisticses data of various upper respiratory tract infection patients using medicine of the present invention：
Through the Clinical practice of 150 patients, wherein male patient 81, female patient 69, medication age object 12 ~ 40 years old.Wherein Minimum 13 years old, maximum 39 years old, 22 years old mean age；Mild upper respiratory inflammation case 74, moderate upper-respiratory inflammation case 43, severe upper respiratory tract infection case 33.
Wherein mild upper respiratory inflammation patient symptom is：Patient feels pharyngeal sense of discomfort, and feels that throat is dry and itch, Discontinuity cough occurs, often more frequent with early morning cough at dusk；
Moderate upper-respiratory inflammation patient's symptom is：Patient often have pharyngalgia, shed tears, the disease such as hypogeusia, hypopnea, hoarseness Shape, and it is also accompanied by cough, dry pharynx, itching throat or burning sensation, there are water clock sense, headache, heating, fear of cold after nose, or even fever occurs Symptom；
Severe upper respiratory tract infection patient's symptom is：Patient has sore throat unbearably, swallows liquid or saliva also occurs play Strong pain, and the situation of dysphagia occurs；And cough constantly, and sputum mixed with blood, fever, general weakness, nose, pharynx, larynx are bright Aobvious congested, edema, submandibular lymph nodes enlargement, tenderness.
Model case：
1st, Wang, female, 22 years old, cough in the obvious inducement of January Yu Qianwu, is that monophone is coughed, no expectorant, with low grade fever, body temperature highest 37.8 DEG C, with fear of cold, abdominal distention, acid regurgitation, stomach poor appetite, no with diarrhoea stomachache, go to a doctor to hospital outpatient, diagnose " upper respiratory tract sense Dye ", gives western medicine, remission.Traveled with household before 3 weeks, period occurs generating heat again, and up to 42 DEG C of body temperature, with fear Cold, shiver with cold, and vomit once, it is gastric content, with cough and expectoration, be that monophone is coughed, expectorant is few, be yellow purulent sputum, outpatient service is given and being brought down a fever Deng treatment after still repeatedly generate heat；And treated using the Chinese medicine formula in the present invention, after three courses for the treatment of, body low grade fever symptom disappears Move back, the symptom such as fear of cold, abdominal distention has been alleviated, and cough symptom is clearly better；After five courses for the treatment of, cough symptom substantially to disappear, Appetite is recovered, and sleep quality improves.
2nd, Zhao, man, 27 years old, due to often on business trips, and is engaged in market sale position, the daily schedule is irregular, warp Often drink excessive drinking, guest invited to a dinner party family drinks the late into the night, and amusement of playing card of often staying up late, heavy drinking before 2 months, suffer from cold after occur coughing, Repeatedly cough for paroxysmal, about 20 times/hour, sucking cold air, smog etc. can induce, and occur more than daytime, feel tachypnea during cough, With itching throat, clear nasal discharge, no heating, fear of cold, shiver with cold, no expectoration, spitting of blood, no pant, uncomfortable in chest, cardiopalmus, tachypnea after non-activity, exhale Inhale difficult, outpatient service is treated with " upper respiratory tract infection "（Specifically unknown）Afterwards, impurity free vacancy disordering tears, but still recurrent cough.January Qianmen indagation Rabat shows no obvious abnormalities, non-special handling.Before 7 days, heating occurred, body temperature fluctuation is in 38 DEG C about；Then adopt the present invention's Chinese medicine formula carries out the treatment of five courses for the treatment of, and by the observation of a period of time, cough symptom has been cured and no longer recurred, and gas The resolution of symptoms such as rush, itching throat.
Although an embodiment of the present invention has been shown and described, it will be understood by those skilled in the art that：Not Multiple changes, modification, replacement and modification can be carried out to these embodiments under the principle of the disengaging present invention and objective, the present invention's Scope is limited by claim and its equivalent.

Claims (5)

1. a kind of Chinese medicine composition treating upper respiratory tract infection it is characterised in that：Described pharmaceutical compositions include Thallus Laminariae (Thallus Eckloniae) 3-9 part, Radix Aconiti Lateralis Preparata 5-8 part, Radix Platycodoniss 4-11 part, Folium Eriobotryae 6-10 part, Herba Lysionoti Pauciflori 5-14 part, Flos Inulae 3-7 part, Folium Elaeagni 5-13 Part, Herba Gnaphalii Affinis 2-9 part, Radix Asteriss 6-12 part, Sargassum 4-8 part.
2. a kind of Chinese medicine composition treating upper respiratory tract infection according to claim 1 it is characterised in that：Described Thallus Laminariae (Thallus Eckloniae) 7 parts, 5 parts of Radix Aconiti Lateralis Preparata, 5 parts of Radix Platycodoniss, 7 parts of Folium Eriobotryae, 11 parts of Herba Lysionoti Pauciflori, 4 parts of Flos Inulae, 7 parts of Folium Elaeagni, 8 parts of Herba Gnaphalii Affinis, Radix Asteriss 9 parts, 6 parts of Sargassum.
3. a kind of Chinese medicine composition treating upper respiratory tract infection according to claim 1 it is characterised in that：Described Thallus Laminariae (Thallus Eckloniae) 9 parts, 7 parts of Radix Aconiti Lateralis Preparata, 10 parts of Radix Platycodoniss, 6 parts of Folium Eriobotryae, 5 parts of Herba Lysionoti Pauciflori, 3 parts of Flos Inulae, 6 parts of Folium Elaeagni, 3 parts of Herba Gnaphalii Affinis, Radix Asteriss 7 parts, 5 parts of Sargassum.
4. a kind of Chinese medicine composition treating upper respiratory tract infection according to claim 1 it is characterised in that：Described Thallus Laminariae (Thallus Eckloniae) 3 parts, 6 parts of Radix Aconiti Lateralis Preparata, 8 parts of Radix Platycodoniss, 9 parts of Folium Eriobotryae, 8 parts of Herba Lysionoti Pauciflori, 5 parts of Flos Inulae, 11 parts of Folium Elaeagni, 5 parts of Herba Gnaphalii Affinis, Radix Asteriss 6 parts, 7 parts of Sargassum.
5. a kind of Chinese medicine composition treating upper respiratory tract infection according to any one of claim 1 ~ 4 it is characterised in that： Described Radix Aconiti Lateralis Preparata is Rhizoma Typhonii.
CN201610995438.7A 2016-11-11 2016-11-11 Traditional Chinese medicine composition for treating upper respiratory inflammation Withdrawn CN106389569A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610995438.7A CN106389569A (en) 2016-11-11 2016-11-11 Traditional Chinese medicine composition for treating upper respiratory inflammation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610995438.7A CN106389569A (en) 2016-11-11 2016-11-11 Traditional Chinese medicine composition for treating upper respiratory inflammation

Publications (1)

Publication Number Publication Date
CN106389569A true CN106389569A (en) 2017-02-15

Family

ID=59230173

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610995438.7A Withdrawn CN106389569A (en) 2016-11-11 2016-11-11 Traditional Chinese medicine composition for treating upper respiratory inflammation

Country Status (1)

Country Link
CN (1) CN106389569A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102973824A (en) * 2012-11-22 2013-03-20 项孝泓 Chinese traditional medicine composite for curing upper respiratory tract infection
CN103110918A (en) * 2013-02-26 2013-05-22 周艳珍 Medicine for treating upper respiratory infection

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102973824A (en) * 2012-11-22 2013-03-20 项孝泓 Chinese traditional medicine composite for curing upper respiratory tract infection
CN103110918A (en) * 2013-02-26 2013-05-22 周艳珍 Medicine for treating upper respiratory infection

Similar Documents

Publication Publication Date Title
CN103920106A (en) Traditional Chinese medicinal composition for treating bronchitis and bronchial asthma
CN104491356A (en) Traditional Chinese medicine composition for treating swollen sore throat and chronic pharyngitis
CN102872325A (en) Traditional Chinese medicine for treating children cough
CN106389569A (en) Traditional Chinese medicine composition for treating upper respiratory inflammation
CN106266542A (en) A kind of Chinese medicine formula treating cough
CN106361903A (en) Preparation method of traditional Chinese medicine composition capable of relieving swollen sore throat
CN106344721A (en) Traditional Chinese medicine composition for relieving swollen sore throat
CN103784534A (en) Traditional Chinese medicine aerosol used for preventing and treating children heat asthma
CN104147334A (en) Traditional Chinese medicine formula capable of eliminating phlegm
CN104096198A (en) Traditional Chinese medicine for treating children's cold
CN106389570A (en) Preparation method of traditional Chinese medicine composition for treating upper respiratory inflammation
CN106362029A (en) Traditional Chinese medicine composition capable of treating chronic pharyngitis
CN103566029B (en) Pharmaceutical composition for treating respiratory diseases and preparation method and usage thereof
CN106421484A (en) Traditional Chinese medicine composition for treating bronchitis
CN102727589B (en) Medicament for treating cough with lung heat of children
CN108653552B (en) Traditional Chinese medicine for clearing lung and relieving cough
CN100998745A (en) Oral traditional Chinese medicine for treating asthma of deficiency of yin
CN117899162A (en) Traditional Chinese medicine composition and preparation for treating chronic pharyngitis and preparation method thereof
CN104127504B (en) Infantile common cold cough syrup and preparation method thereof
CN104258116A (en) Oral liquid for treating viral influenza
CN104013932B (en) Traditional Chinese medicine pill for treating endogenous cough
CN104873716A (en) Traditional Chinese medicine for treating chronic superficial gastritis combined chronic pharyngitis
CN104491820A (en) Traditional Chinese medicine formula for treating pediatric pertussis
CN103463413B (en) The decoction for the treatment of hypertrophy of tonsils
CN104189610A (en) Traditional Chinese medicine composition for treating bronchitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication
WW01 Invention patent application withdrawn after publication

Application publication date: 20170215